
News from NewMediaWire
Media Bias Ratings
Do you diasgree?
Edit bias
Learn more about Media Bias Ratings.
Factuality
Learn more about Factuality Ratings
Reveal Factuality Ratings by upgrading to a Premium account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Ownership
Learn more about Ownership categories
Reveal Ownership Data by upgrading to a Vantage account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Top NewMediaWire News

Diabetes · United StatesBy Sandee LaMotte, CNN (CNN) — Sign up for CNN’s Life, But Greener newsletter. Our limited newsletter series guides you on how to minimize your personal role in the climate crisis — and reduce your eco-anxiety. Living near heavily microplastic-polluted waters along the United States coastline may significantly raise the risk of developing type 2 diabetes, stroke and coronary artery disease, a condition in which plaque blocks the blood vessels fe…See the Story
Health Harms Linked to Living Near Highly Microplastic-Polluted US Coastlines, Study Finds
90% Center coverage: 39 sources

Artificial IntelligenceThe demand for uranium is experiencing a significant surge, driven by the growing interest in artificial intelligence (AI) and the global push towards nuclear energy as a cleaner alternative. With nuclear energy being recognized for its low greenhouse gas emissions and high capacity, uranium’s role as a critical mineral has come into sharp focus. The U.S., which currently relies heavily on imports for its uranium needs, is making concerted effor…See the Story
Uranium Demand Surges Amid AI Growth and Nuclear Energy Push

United States · United StatesThe recent U.S. Food and Drug Administration (FDA) approval of Keytruda® (pembrolizumab) for the treatment of resectable, locally advanced head and neck squamous cell carcinoma (HNSCC) has significant implications for the development of combination therapies, including GeoVax Labs, Inc.’s Gedeptin®. This approval not only marks a pivotal advancement in the treatment of head and neck cancer but also validates the therapeutic approach behind GeoVa…See the Story